Brennan Daniel J.insider trades

In SEC Form 4 filings, Brennan Daniel J. is listed as Director of Vertex Pharmaceuticals Inc / Ma (VRTX). Brennan Daniel J. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 22.

Companies and roles

Company	Role	Transactions	Last filed
VRTXVertex Pharmaceuticals Inc / Ma	Director	1	Oct 22

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-22

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
VRTXVertex Pharmaceuticals Inc / Ma	Oct 20	Oct 22	A	795	$503.47	$400,259	795	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.